These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12270731)

  • 21. The lipopolysaccharide of moraxella catarrhalis structural relationships and antigenic properties.
    Holme T; Rahman M; Jansson PE; Widmalm G
    Eur J Biochem; 1999 Oct; 265(2):524-9. PubMed ID: 10504382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemical structure of bacterial endotoxin in relation to bioactivity.
    Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
    Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An NMR spectroscopy and molecular mechanics study of the molecular basis for the supramolecular structure of lipopolysaccharides.
    Wang Y; Hollingsworth RI
    Biochemistry; 1996 May; 35(18):5647-54. PubMed ID: 8639523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide: Biosynthetic pathway and structure modification.
    Wang X; Quinn PJ
    Prog Lipid Res; 2010 Apr; 49(2):97-107. PubMed ID: 19815028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial lipopolysaccharide binding to host receptors.
    Hazlett LD
    Trends Microbiol; 1996 Nov; 4(11):418. PubMed ID: 8950808
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacterial lipopolysaccharide and its lipid A component: some historical and some current aspects.
    Westphal O; Lüderitz O; Rietschel ET; Galanos C
    Biochem Soc Trans; 1981 Jun; 9(3):191-5. PubMed ID: 7274542
    [No Abstract]   [Full Text] [Related]  

  • 27. The gram-negative outer membrane: structure, biochemistry and vaccine potential.
    Owen P
    Biochem Soc Trans; 1992 Feb; 20(1):1-6. PubMed ID: 1633932
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of the surface architecture of gram-negative bacteria by the action of surface polymer:lipid A-core ligase and by determinants of polymer chain length.
    Whitfield C; Amor PA; Köplin R
    Mol Microbiol; 1997 Feb; 23(4):629-38. PubMed ID: 9157235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of endotoxin and its impact on pathogenesis.
    Trent MS; Stead CM; Tran AX; Hankins JV
    J Endotoxin Res; 2006; 12(4):205-23. PubMed ID: 16953973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides.
    Lapaque N; Takeuchi O; Corrales F; Akira S; Moriyon I; Howard JC; Gorvel JP
    Cell Microbiol; 2006 Mar; 8(3):401-13. PubMed ID: 16469053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Lipid A from the haloalkaliphilic bacterium Salinivibrio sharmensis strain BAG(T).
    Carillo S; Pieretti G; Lindner B; Romano I; Nicolaus B; Lanzetta R; Parrilli M; Corsaro MM
    Mar Drugs; 2013 Jan; 11(1):184-93. PubMed ID: 23337252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification from a positional scanning peptoid library of in vivo active compounds that neutralize bacterial endotoxins.
    Mora P; Masip I; Cortés N; Marquina R; Merino R; Merino J; Carbonell T; Mingarro I; Messeguer A; Pérez-Payá E
    J Med Chem; 2005 Feb; 48(4):1265-8. PubMed ID: 15715495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation.
    Asai Y; Makimura Y; Kawabata A; Ogawa T
    J Immunol; 2007 Dec; 179(11):7674-83. PubMed ID: 18025213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lipopolysaccharide of Shigella bacteria as a virulence factor.
    Lindberg AA; Kärnell A; Weintraub A
    Rev Infect Dis; 1991; 13 Suppl 4():S279-84. PubMed ID: 1710816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide-binding protein.
    Schumann RR; Latz E
    Chem Immunol; 2000; 74():42-60. PubMed ID: 10608081
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular mechanisms of membrane targeting antibiotics.
    Epand RM; Walker C; Epand RF; Magarvey NA
    Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What we know and don't know about the chemical and physical structure of lipopolysaccharide in relation to biological activity.
    Müller-Loennies S; Zähringer U; Seydel U; Kusumoto S; Ulmer AJ; Rietschel ET
    Prog Clin Biol Res; 1998; 397():51-72. PubMed ID: 9575547
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular genetic manipulation of nonenteric bacterial pathogens to synthesise altered lipopolysaccharide molecules.
    Maskell D; Allen A; Khan S; Servos S
    Prog Clin Biol Res; 1995; 392():35-47. PubMed ID: 8524941
    [No Abstract]   [Full Text] [Related]  

  • 40. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action.
    Freudenberg MA; Galanos C
    Int Rev Immunol; 1990; 6(4):207-21. PubMed ID: 2102904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.